Subcellular localisation of cyclin B, Cdc2 and p21WAF1/CIP1 in breast cancer
- 1 December 2001
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 37 (18), 2405-2412
- https://doi.org/10.1016/s0959-8049(01)00327-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cellsOncogene, 1998
- A measure of the mitotic index: studies of the abundance and half‐life of p34cdc2in cultured cells and normal and neoplastic tissuesGenes to Cells, 1998
- WAF1/CIP1 protein expression in human breast tumorsBreast Cancer Research and Treatment, 1997
- p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatmentEuropean Journal Of Cancer, 1996
- THE LOCALIZATION OF p34cdc2 IN THE CELLS OF NORMAL, HYPERPLASTIC, AND MALIGNANT EPITHELIAL AND LYMPHOID TISSUES OF THE ORAL CAVITYThe Journal of Pathology, 1996
- p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.Proceedings of the National Academy of Sciences, 1995
- Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Redundant cyclin overexpression and gene amplification in breast cancer cells.Proceedings of the National Academy of Sciences, 1993
- Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.The Journal of cell biology, 1991